SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-22-262985
Filing Date
2022-10-14
Accepted
2022-10-14 16:32:16
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 d287522ds3.htm S-3 226942
2 EX-5.1 d287522dex51.htm EX-5.1 10049
3 EX-23.1 d287522dex231.htm EX-23.1 1596
4 EX-FILING FEES d287522dexfilingfees.htm EX-FILING FEES 43842
5 GRAPHIC g287522dsp001.jpg GRAPHIC 2453
6 GRAPHIC g287522dsp1a.jpg GRAPHIC 12507
7 GRAPHIC g287522dsp2.jpg GRAPHIC 2453
8 GRAPHIC g287522g02m23.jpg GRAPHIC 90211
  Complete submission text file 0001193125-22-262985.txt   432300
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-267888 | Film No.: 221311656
SIC: 2834 Pharmaceutical Preparations